Chronic Itch? Arthritis Drug is Potential New Therapy Fighting Itch

Itching and scratching consumed Karen Berger’s life until she met dermatologist Dr. Brian Kim. The itching was all over her body. She described it as unbearable, unrelenting, uncontrollable and untreatable. No one could diagnose the cause. Dr. Kim prescribed the anti-inflammatory drug Xeljanz, a rheumatoid arthritis medication. It’s a potential new therapy for chronic itch. Kim is co-director of the Center for the Study of Itch (CSI) at Washington University School of Medicine in St. Louis. Through his research, Kim is able to help some chronic itch patients who have a type of itch from an unknown cause, a condition called idiopathic pruritus. Kim led a small study providing proof that Xeljanz works for chronic itch patients.

Kathleen Berger
Executive Producer, HEC Science & Technology
Subscribe now ➤ https://bit.ly/2Lf0zWA

For more great content from the Higher Education Channel check us out at:
Facebook ➤ http://bit.ly/1WPZEek
Twitter ➤ http://bit.ly/22qZDNU
Instagram ➤ http://bit.ly/1THSOnM

Видео Chronic Itch? Arthritis Drug is Potential New Therapy Fighting Itch канала HEC Science & Technology